Precision Medicine, CRISPR, and Genome Engineering Moving from Association to Biology and Therapeutics

(Dana P.) #1

102


6.1 Introduction

The past decade has seen massive strides in the direction of development and


identification of technologies that would help in precise targeting of the genome to


create mutations at specific locations or precise insertion of desired sequences in a


particular location. Genome editing, as it is commonly known, is now a routine and


easy practice that is performed in laboratories around the world and on a variety of


organisms. This involves the use of synthetic nucleases that can create DNA double-


stranded breaks (DSBs) and mutations that subsequently arise when the break is


repaired by the endogenous DNA repair mechanism of the organism. Initially,


technologies such as homing-endonucleases or meganucleases [ 1 , 2 ], zinc finger


nucleases (ZFN) [ 3 , 4 ], and transcription activator-like effector nucleases (TALENs)


[ 5 , 6 ] were adopted for targeted edits or changes in a genome. But, in the past few


years, a new technology has come to the fore. Isolated and derived from the pro-


karyotic immune system, the clustered regularly interspaced short palindromic


repeats system (or CRISPR system for short) has had a massive effect on increasing


the feasibility of precision genome editing [ 7 – 11 ].


One of the most attractive features of the CRISPR system is its flexible nature,

allowing greater leeway for targeting locations of interest within the genome and


hence causing it to be adopted widely [ 12 – 16 ]. The CRISPR system is a single


sequence or stranded DNA recognition tool and can cause breaks in a specific loca-


tion within the genome. Another added advantage is that the CRISPR/CRISPR-


associated protein (CRISPR/Cas) system can help create modified plants that can


avoid regulatory classifications generally associated with transgenic plants in cer-


tain countries [ 17 ]. Moreover, the simplicity of the components required for such an


experiment is also an added advantage, since CRISPR/Cas depends on only two


components to show its activity: single guide RNA (sgRNA) and CRISPR-associated


protein or effector.


Taking into account the current agricultural scenario and the always present need

to have crops with stronger and improved traits such as increased yield or enhanced


pathogen resistance, genome editing has been performed on plants with great


success. The CRISPR system has been quite widely used with plants in the last


couple of years, with research encompassing plants from a wide range of plant fami-


lies and genera. CRISPR has been applied to model plants such as Arabidopsis


thaliana [ 18 – 20 ] and Nicotiana benthamiana [ 10 ] and other important crop plants


such as Solanum tuberosum [ 21 ], Triticum aestivum [ 11 , 22 ], and finally Oryza


sativa [ 7 , 11 , 19 , 20 ]. Consistent research on food crops will greatly benefit the


world as more improved varieties can be identified and obtained by introductions of


targeted mutations and new traits. In this chapter, we will take a brief look at the


origin of the CRISPR system and its journey from existence as a bacterial adaptive


immune system to a genome-editing tool. Light will be shed on the application of


the CRISPR system in crop plants and plants in general along with recent modifica-


tions that increase the efficiency of the system.


A. Bandyopadhyay et al.
Free download pdf